Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 834 of 1,261

  1. US 8632782

    Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  2. US 8632751

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Universitair Medisch Centrum Utrecht · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  3. US 8632771

    High molecular weight derivatives of vitamin K-dependent polypeptides

    The United States of America as represented by Department of Veterens Affairs · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  4. US 8632510

    Nanochanneled device and related methods

    The Board of Regents of the University of Texas System · Granted Jan 21, 2014 · Expires Jan 16, 2034

    granted

  5. US 8628962

    Differentiation of stem cells into dopaminergic cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  6. US 8629141

    Spiro-oxindole MDM2 antagonists

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  7. US 8629156

    Tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  8. US 8629177

    Nanoencapsulated delta-9-tetrahydrocannabinol

    Aphios Corporation · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  9. US 8629162

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  10. US 8628764

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  11. US 8628769

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  12. US 8629119

    Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

    The Board of Regents of the University of Texas System · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  13. US 8628917

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  14. US 8629127

    Compositions and methods of treatment for inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  15. US 8628782

    Deletion of the beta 20-21 loop in HIV gp120 exposes the CD4 binding site for improved antibody binding and antibody induction

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  16. US 8629260

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  17. US 8628780

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  18. EP 2682113

    Verschließen wirkstoffhaltiger Laminate

    ACINO AG [DE] · Granted Jan 8, 2014 · Expires Jan 3, 2034

    granted

  19. US 8623614

    Method for the recombinant production of magnetic nanoparticles

    Ludwig-Maximilians-Universitat Munchen · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  20. US 8623847

    Compositions for treatment of inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  21. US 8624032

    Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions

    The Regents of the University of California · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  22. US 8623905

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  23. US 8623917

    Uses of prostacyclin analogs

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  24. US 8623867

    Cyclic amine BACE-1 inhibitors having a benzamide substituent

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.